消化器系がんの治療決定におけるオルガノイドの適用:進展と課題
Yufei Wang1, Limin Zhang2,3, Louis Zizhao Wang4,5
1School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, 434023, China.
Molecular cancer
|August 25, 2025
まとめ
患者から得られたがんオルガノイドは 消化器がんの個別化薬剤検査を行い 治療戦略を改善します オーガノイド技術の進歩により 予測の精度と臨床応用が向上し 患者の治療結果が改善されています
科学分野:
- 腫瘍学
- バイオテクノロジー
- パーソナライズ された 医療
背景:
- 消化器系がん (胃,肝臓,大腸,食道,臓) は,がんによる死亡の主な原因です.
- 治療への耐性症候群の進行は大きな課題となっています.
- パーソナライズされた腫瘍生物学を複製する患者由来がん器官 (PDCOs)
研究 の 目的:
- 消化器系がんのPDCO技術の進歩をレビューする.
- パーソナライズド・トリートメントの意思決定におけるPDCOの可能性を強調する.
- 研究室での研究と臨床での応用を結びつけるため
主な方法:
- PDCO を用いて薬剤を予測する (化学療法,放射線療法,標的療法,免疫療法).
- PDCOの限界を克服するために新興技術 (AI,オルガン・オン・チップ,3Dバイオプリント) を探求する.
- ネオアジュバント療法における臨床試験の応用とリアルタイムの治療ガイドラインの分析
主要な成果:
- PDCOは,治療への反応を予測する優れた精度を示しています.
- 現在の制限には,不完全な腫瘍の微小環境,変数定着率,および長い処理時間が含まれる.
- 新興技術と臨床試験は これらの課題に積極的に取り組んでいます
結論:
- PDCO技術は 消化器がんの治療に 変革をもたらす可能性を秘めています
- PDCOは個々の腫瘍生物学に基づく 個別化された治療戦略を可能にします
- 進歩はPDCOの臨床ケアへの統合を容易にする.
さらに関連する動画
関連する概念動画
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...